Status:
ACTIVE_NOT_RECRUITING
Improving Diagnostic Accuracy for Acute Heart Failure
Lead Sponsor:
Vanderbilt University Medical Center
Collaborating Sponsors:
Wayne State University
Conditions:
Acute Heart Failure
Dyspnea
Eligibility:
All Genders
18+ years
Brief Summary
Acute heart failure is a common reason for emergency department visits and hospitalization, but the diagnosis can be challenging because of non-specific symptoms and signs. The current diagnostic appr...
Detailed Description
Acute heart failure (HF) is highly morbid, lethal, and costly. It is a difficult diagnosis to make given its symptoms and signs overlap with other cardiac and non-cardiac conditions. In the emergency ...
Eligibility Criteria
Inclusion
- For enrollment into the prospective cohort for Outcome 3.
- Willing to adhere to the study protocol
- Able to provide written consent
- English or Spanish speaking
- Adult, defined as 18 years or older
- Primary reason for presentation to the ED is dyspnea
- ED physician is considering a diagnosis of HF, defined by ordering a NP test and/or a chest x-ray
Exclusion
- History of end-stage renal disease for which hemodialysis is needed
- Dyspnea due to primary presentation of an acute coronary syndrome or trauma
Key Trial Info
Start Date :
August 31 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2026
Estimated Enrollment :
2800 Patients enrolled
Trial Details
Trial ID
NCT04886128
Start Date
August 31 2021
End Date
June 30 2026
Last Update
August 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232